IIT Madras has launched a biotechnology finishing school that will train graduates through laboratory work, pilot-scale exposure and industry internships, in an effort to align academic learning with the practical requirements of India’s biotechnology and biomanufacturing sectors.
The programme, called UDYOG, or Upskilling and Development for YOung Graduates, was inaugurated by IIT Madras Director V. Kamakoti. It is being implemented through SynBioME and the IIT-M-TICEL Biofoundry, and is open to pre-final and final-year BTech, MTech and MSc students in biotechnology and allied disciplines across India.
According to the details reported by Deccan Chronicle, UDYOG will combine online courses with intensive laboratory training, pilot-scale experience and industry internships. The structure is intended to give students exposure to processes and working environments that may not be fully available through conventional classroom-based academic programmes.
The first batch is scheduled to begin on January 18, 2027. Early-bird registration will close on December 15, 2026, and interested students can submit an expression of interest through the IIT Madras-TICEL Biofoundry website.
The initiative comes as biotechnology education increasingly needs to connect scientific knowledge with production, experimentation and industry practices. While the programme is specifically focused on biotechnology graduates, its design reflects a wider shift in technical education towards applied training and closer interaction between academic institutions and employers.
Kamakoti said the programme was also linked to the growing importance of artificial intelligence across science and engineering. “AI also means Academia-Industry. It is becoming an absolute necessity that every discipline of Science and Engineering must look at this AI with care to make themselves relevant to the modern world. UDYOG is yet another effort taken by IIT-M in this direction,” he said.
The programme’s delivery through the IIT-M-TICEL Biofoundry gives the initiative a laboratory and pilot-scale orientation rather than limiting it to online instruction. The institution has not, in the supplied announcement, specified the number of seats, programme fee, duration of the internships or the companies expected to participate.
For students, the key distinction will be access to practical training and industry exposure before graduation. For the biotechnology sector, the programme represents an institutional attempt to address the transition between university qualifications and workplace requirements. Further details are expected through the registration process ahead of the first batch’s January 2027 start.
